Mindray and ZONARE Integrate Ultrasound Sales and Clinical Teams in North America

//Mindray and ZONARE Integrate Ultrasound Sales and Clinical Teams in North America

Mindray and ZONARE Integrate Ultrasound Sales and Clinical Teams in North America

Mountain View, CA – February 1, 2016

Combined Group to Offer Extensive Array of Ultrasound Imaging Solutions

Mindray and ZONARE Medical Systems, developers of next generation ultrasound technology, announced the integration of both sales and clinical ultrasound sales teams throughout North America. Effective February 1, 2016, the combined group will now offer an extensive array of ultrasound imaging solutions featuring each entity’s respective technology. Glen McLaughlin, PhD, currently the president of ZONARE, will assume the additional role of executive vice president for Mindray North America ultrasound. ZONARE was acquired by Mindray in June 2013.

“Combining our two groups allows us to leverage our technologies which will expand solutions for our customers,” said McLaughlin. “The integration of sales and field clinical professionals will enable us to provide a comprehensive line of imaging options each suited for specific clinical environments. We believe this will better serve our customers’ needs and look forward to our ongoing customer partnerships.”

McLaughlin will report to Menge Cheng, co-CEO of Mindray International, and also have a dotted line to Wayne Quinn, president of Mindray North America, for the profit and loss of the North American ultrasound market. The newly combined sales and clinical group will report to Steve Edwards, vice president of ultrasound direct sales for North America, who was formerly vice president of ZONARE U.S. ultrasound. Edwards will continue to report to McLaughlin who is located at ZONARE headquarters in Silicon Valley. Reporting to Edwards will be Craig Dickinson, director of sales U.S., and Vince Arsenault, director of sales Canada.

The combined entity will offer Mindray’s TE-7, M-7, DC-8 and M-9 ultrasound systems, as well as ZONARE’s Z.One PRO and ZS3 platforms, based on ZONE Sonography® Technology (ZST). Future developments will feature integration of technologies and extensive application capabilities.

“The combination of our mutual strengths will enable more robust choices and better solutions,” said McLaughlin. “This will support the goal of providing our clinical partners with state-of-the-art ultrasound imaging technology in offering excellence in patient care.”

About Mindray

Mindray, established in 1991, is a leading international manufacturer of medical equipment with global headquarters in Shenzhen, China, North American headquarters in Mahwah, NJ, and R&D centers on 3 continents. We offer a broad range of medical solutions to clinicians including medical imaging, patient monitoring & life support, and diagnostic products. Mindray’s recent acquisition of Zonare, a leader in innovative ultrasound technology, leverages a compendium of imaging products designed to meet our customers’ evolving needs for high-end image quality, clinical versatility, and unparalleled value. For more information visit www.mindray.com.

About ZONARE

ZONARE is solely dedicated to ultrasound excellence through its innovative, award-winning next generation technology which provides the platform for the company’s Living Technology designed to meet its customers evolving imaging needs. The patented design and Zone Sonography ™ Technology (ZST) architecture of the Z.One PRO and ZS3 platforms deliver high-end image quality and clinical versatility. ZONARE is now an independently run, wholly owned subsidiary of Mindray Medical International.

Media Contact:
Laurie Hallwyler
650-248-9081
lhallwyler@zonare.com

2017-09-03T22:11:10+00:00 02-01-2016|